糖原储存疾病Ia型:追溯索赔分析并发症,资源利用和护理成本
Eliza Kruger1, Justin Nedzesky1, Nina Thomas1
1Ultragenyx Pharmaceutical Inc., Novato, CA, USA.
Journal of health economics and outcomes research
|January 10, 2025
概括
糖原储存疾病类型Ia (GSDIa) 会导致严重的并发症和高医疗费用. 与一般人群相比,患有GSDIa的患者经历了更多的住院治疗,急诊和每年医疗费用显著增加.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学和遗传性疾病
- 临床研究和流行病学.
背景情况:
- 糖原储存疾病Ia型 (GSDIa) 是一种罕见的遗传代谢障碍.
- 它可能导致严重的低血糖,代谢障碍和需要医疗干预的严重并发症.
研究的目的:
- 分析大量GSDIa患者队列中的并发症,医疗保健资源利用率和相关成本.
- 将这些结果与没有GSDIa的匹配队列进行比较.
主要方法:
- 使用PharMetrics® Plus数据库进行的回顾性队列研究 (2016年1月至2020年2月).
- 使用ICD-10代码识别GSDIa患者和匹配的非GSDIa比较者.
- 评估各种环境 (住院,门诊,ED,药房) 的医疗保健利用情况以及相关成本.
主要成果:
- GSDIa患者的并发症发生率显著增加,包括贫血,肝细胞腺瘤,肝移植,胃口,酸性,肝壮,高尿血和低血糖症.
- 急性 (例如低血糖,) 和慢性 (例如痛风,CKD) 的并发症在GSDIa患者中更为普遍.
- GSDIa患者需要更多的住院治疗 (0.53对每名患者/年0.06),更长的住院时间,以及更频繁的急诊室访问 (4.3倍以上).
- 对于GSDIa患者来说,平均年度医疗费用明显高 (几乎是比较者高的8倍).
结论:
- GSDIa与广泛的严重,可能致命的并发症有关.
- 这种疾病需要大量利用医疗保健资源.
- 对GSDIa的管理造成了相当高的医疗保健成本.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Diabetes: Symptoms, Diagnosis, and Complications
501
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
501
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Pathophysiology of Diabetes
860
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
860


